Linker Information
General Information of This Linker
| Linker ID |
LIN0DYKJL
|
|||||
|---|---|---|---|---|---|---|
| Linker Name |
Geranyl ketone pyrophosphate oxime ligation
|
|||||
| Linker Type |
CaaX-motif based site-specific conjugation linker
|
|||||
| Antibody-Linker Relation |
Cleavable
|
|||||
| Structure |
|
|||||
| Formula |
C34H52N2O12S
|
|||||
| Isosmiles |
CSC/C=C(\C)CC/C=C(\C)CC/C(C)=N/OCCOCCOCCNC(=O)c1cc(CO)ccc1OC1OC(C(=O)O)C(O)C(O)C1O
|
|||||
| InChI |
InChI=1S/C34H52N2O12S/c1-22(6-5-7-23(2)12-19-49-4)8-9-24(3)36-46-18-17-45-16-15-44-14-13-35-32(41)26-20-25(21-37)10-11-27(26)47-34-30(40)28(38)29(39)31(48-34)33(42)43/h6,10-12,20,28-31,34,37-40H,5,7-9,13-19,21H2,1-4H3,(H,35,41)(H,42,43)/b22-6+,23-12+,36-24+
|
|||||
| InChIKey |
WTEPMOWYUFGBCI-XWZVYFMSSA-N
|
|||||
| Pharmaceutical Properties |
Molecule Weight
|
712.859
|
Polar area
|
205.83
|
||
|
Complexity
|
49
|
xlogp Value
|
2.4214
|
|||
|
Heavy Count
|
49
|
Rot Bonds
|
23
|
|||
|
Hbond acc
|
13
|
Hbond Donor
|
6
|
|||
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
LCB14-0110 [Phase 3]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Objective Response Rate (ORR) |
66.70% (> 1.00 mg/kg)
42.90% (HER2-Low) |
|||
| Patients Enrolled |
Patients with HER2-expresssing advanced solid tumors who had failed prior standard of care therapies.
|
||||
| Administration Dosage |
FS-1502 was given IV once in 21-day or 28-day cycle at doses of 0.10-3.50 mg/kg.
|
||||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.